A thylakoid-based immunometabolic reprogramming platform for ultrasound-activated extracellular matrix remodeling and antitumor immunity
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Cancer Research and Treatments · Nanoplatforms for cancer theranostics · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Benmelstobart plus anlotinib and chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a phase 2 study
2. A polymeric extracellular matrix nanoremodeler for activatable cancer photo-immunotherapy
3. Sequential drug release system: Targeting the tumor ECM for enhanced chemotherapy efficacy10.1073/pnas.2421061122 ↗
4. Extracellular matrix educates an immunoregulatory tumor macrophage phenotype found in ovarian cancer metastasis10.1038/s41467-023-38093-5 ↗
5. Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment10.1038/s43018-024-00775-4 ↗
6. Extracellular matrix and its therapeutic potential for cancer treatment10.1038/s41392-021-00544-0 ↗
7. Harnessing the chemokine system to home CAR-T cells into solid tumors
8. Nattokinase-Mediated Regulation of Tumor Physical Microenvironment to Enhance Chemotherapy, Radiotherapy, and CAR-T Therapy of Solid Tumor10.1021/acsnano.2c12463 ↗
9. Dual Strategy of Ca2+ Influx and Collagen Denaturation to Remodel the Extracellular Matrix and Amplify Sonopiezoelectric Therapy
10. The complex role of tumor-infiltrating macrophages10.1038/s41590-022-01267-2 ↗
11. Macrophages and T cells in metabolic disorder-associated cancers10.1038/s41568-024-00743-1 ↗
12. CAF-induced physical constraints controlling T cell state and localization in solid tumours10.1038/s41568-024-00740-4 ↗
13. The advent of immune stimulating CAFs in cancer10.1038/s41568-023-00549-7 ↗
14. The roles of arginases and arginine in immunity10.1038/s41577-024-01098-2 ↗
15. Classically activated macrophages undergo functionally significant nucleotide metabolism remodelling driven by nitric oxide10.1038/s42255-025-01337-3 ↗
16. Polymerization of L-Arginine into Nanomicelles for Immunometabolic Engineering of Adoptive Macrophages in Solid Tumor Therapy
17. A Self-Catalytic NO/O2 Gas-Releasing Nanozyme for Radiotherapy Sensitization through Vascular Normalization and Hypoxia Relief
18. Copper-induced injectable hydrogel with nitric oxide for enhanced immunotherapy by amplifying immunogenic cell death and regulating cancer associated fibroblasts10.1186/s40824-023-00389-4 ↗
19. Nitric Oxide-Based Nanomedicines for Conquering TME Fortress: Say “NO” to Insufficient Tumor Treatment10.1002/adfm.202312092 ↗
20. Defects in antigen processing and presentation: mechanisms, immune evasion and implications for cancer vaccine development10.1038/s41577-025-01208-8 ↗
21. Cross-priming in cancer immunology and immunotherapy10.1038/s41568-024-00785-5 ↗
22. Lipoteichoic acid anchor triggers Mincle to drive protective immunity against invasive group A Streptococcus infection10.1073/pnas.1809100115 ↗
23. Thylakoid engineered M2 macrophage for sonodynamic effect promoted cell therapy of early atherosclerosis10.1007/s12274-023-6156-2 ↗
24. Immunomodulatory hybrid bio-nanovesicle for self-promoted photodynamic therapy10.1007/s12274-021-4050-3 ↗
25. Energy Interception-Enhanced Ultrasound-Induced Luminescence Enables Efficient Anticancer Monitoring
26. Nanomaterials-Induced Redox Imbalance: Challenged and Opportunities for Nanomaterials in Cancer Therapy
27. Catalytic Biomaterials-Activated In Situ Chemical Reactions: Strategic Modulation and Enhanced Disease Treatment
28. Enhanced nanoparticle delivery across vascular basement membranes of tumours using nitric oxide10.1038/s41551-025-01385-w ↗
29. TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1+ macrophages10.1038/s41588-025-02380-2 ↗
30. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments10.1038/s41392-025-02325-5 ↗
31. Nitric Oxide Regulates Transforming Growth Factor-β Signaling in Endothelial Cells10.1161/01.RES.0000191538.76771.66 ↗
32. Photo-Triggered Cascade Therapy: A NIR-II AIE Luminogen Collaborating with Nitric Oxide Facilitates Efficient Collagen Depletion for Boosting Pancreatic Cancer Phototheranostics
33. Convergent inducers and effectors of T cell paralysis in the tumour microenvironment10.1038/s41568-024-00761-z ↗
34. Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy10.1186/s12943-025-02407-6 ↗
35. Mitochondrial lipid metabolism in tumor immunosurveillance and evasion10.1016/j.it.2025.08.005 ↗
36. Targeting ROS in cancer: rationale and strategies10.1038/s41573-024-00979-4 ↗
37. Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity10.1039/D4CS00679H ↗
38. Ammonia detoxification promotes CD8+ T cell memory development by urea and citrulline cycles10.1038/s41590-022-01365-1 ↗
39. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid10.1038/s41586-020-03045-2 ↗
40. Transforming growth factor–β1 in regulatory T cell biology10.1126/sciimmunol.abi4613 ↗
41. Metabolic interplay: tumor macrophages and regulatory T cells10.1016/j.trecan.2023.11.007 ↗
42. Overcoming radiation-induced PD-L1 and COX-2 upregulation by nitric oxide gas nanogenerator to sensitize radiotherapy of lung cancer10.1016/j.biomaterials.2025.123335 ↗
43. Systemic therapy for early-stage breast cancer: learning from the past to build the future10.1038/s41571-022-00687-1 ↗
44. Breast cancer: pathogenesis and treatments10.1038/s41392-024-02108-4 ↗
45. Nanotechnology and cell death: Revolutionizing disease treatment with nanoparticle strategies10.1002/VIW.20250033 ↗